[Systemic sclerosis--clinical course and treatment possibilities].

Systemic sclerosis is an autoimmune disease, characterized by fibrosis of the skin and internal organs, such as esophagus, heart, lungs, and kidneys. Three main forms of systemic sclerosis are conspicuous: diffuse systemic sclerosis, limited systemic sclerosis and scleroderma sine sclerosis. Respective variants differ in skin sclerosis exacerbation, progress and prognosis; whereas organ involvement, osseous and articular alterations are comparable in all forms of the disease. Due to the fact that etiology of systemic sclerosis is not known, no specific therapy has been developed. The therapy is based on influencing main pathogenetic factors, such as peripheral circulation disturbances, abnormal immune activation and increase in collagen accumulation. An overview of clinical course of systemic sclerosis and new therapeutic modalities is provided.
AuthorsElzbieta Szymańska, Małgorzata Maj, Lidia Rudnicka
JournalPrzegla̧d lekarski (Przegl Lek) Vol. 62 Issue 12 Pg. 1538-41 ( 2005) ISSN: 0033-2240 [Print] Poland
Vernacular TitleTwardzina układowa--przebieg kliniczny i mozliwości terapeutyczne.
PMID16786791 (Publication Type: English Abstract, Journal Article, Review)
  • Connective Tissue (pathology)
  • Humans
  • Scleroderma, Diffuse (diagnosis, therapy)
  • Scleroderma, Localized (diagnosis, therapy)
  • Scleroderma, Systemic (classification, diagnosis, drug therapy, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: